These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30829578)

  • 1. Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer.
    Fuso L; Ferrero A; Vietti E; Petracchini M; Mineccia M; Villa M; Menato G
    Int J Gynecol Cancer; 2019 Mar; 29(3):599-604. PubMed ID: 30829578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT prediction of surgical outcome in patients with advanced epithelial ovarian carcinoma undergoing neoadjuvant chemotherapy.
    Bregar A; Mojtahed A; Kilcoyne A; Kurra V; Melamed A; Growdon W; Alejandro Rauh-Hain J; Del Carmen M; Lee SI
    Gynecol Oncol; 2019 Mar; 152(3):568-573. PubMed ID: 30642626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of computed tomography in the staging and predicting resectability of primary advanced ovarian carcinoma].
    Lou FL; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):701-5. PubMed ID: 17274380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
    Lof P; van de Vrie R; Korse CM; van Driel WJ; van Gent MDJM; Karlsen MA; Amant F; Lok CAR
    Int J Gynecol Cancer; 2019 Oct; 29(8):1304-1310. PubMed ID: 31515411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study.
    Feng Z; Wen H; Jiang Z; Liu S; Ju X; Chen X; Xia L; Xu J; Bi R; Wu X
    J Gynecol Oncol; 2018 Sep; 29(5):e65. PubMed ID: 30022629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
    Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA
    Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer.
    Kim NY; Jung DC; Lee JY; Han KH; Oh YT
    Korean J Radiol; 2021 Sep; 22(9):1481-1489. PubMed ID: 34132077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
    Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
    Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted magnetic resonance imaging for the pre-operative evaluation of epithelial ovarian cancer patients.
    Feng Z; Fu Y; Li R; Li H; Lu J; Chen X; Ju X; Wu X; Wen H
    Gynecol Oncol; 2023 Jul; 174():142-147. PubMed ID: 37207498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer.
    Son JH; Chang K; Kong TW; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2018 Jul; 44(7):1294-1301. PubMed ID: 29683235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.
    Shim SH; Lee SJ; Kim SO; Kim SN; Kim DY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2015 Jan; 136(1):30-6. PubMed ID: 25448457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging before cytoreductive surgery in advanced ovarian cancer patients.
    Rizzo S; Del Grande M; Manganaro L; Papadia A; Del Grande F
    Int J Gynecol Cancer; 2020 Jan; 30(1):133-138. PubMed ID: 31754068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
    Davidson BA; Broadwater G; Crim A; Boccacio R; Bixel K; Backes F; Previs RA; Salinaro J; Salani R; Moore K; Secord AA
    Gynecol Oncol; 2019 Mar; 152(3):554-559. PubMed ID: 30558972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
    Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
    Costales AB; Crane EK; Chambers L; Yao M; Chau D; Naumann WR; Debernardo R; Ricci S; Rose PG; Michener CM
    Gynecol Oncol; 2024 Jun; 185():143-147. PubMed ID: 38417209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models.
    Rutten MJ; van de Vrie R; Bruining A; Spijkerboer AM; Mol BW; Kenter GG; Buist MR
    Int J Gynecol Cancer; 2015 Mar; 25(3):407-15. PubMed ID: 25695545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer.
    Muallem MZ; Sehouli J; Richter R; Babayeva A; Gasimli K; Parashkevova A
    Int J Gynecol Cancer; 2020 Jan; 30(1):62-66. PubMed ID: 31744887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.